drugset / Trial / NCT00767663

Persantin Preceding Elective PCI

NCT00767663

Phase 4 Completed 30 enrolled Radboud University Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

In this study the investigators will investigate whether a short pretreatment (3-7 days) with dipyridamole 200mg twice daily will protect patients against myocardial injury sustained during an elective dotter operation of the coronary arteries (PCI). The investigators hypothesize that dipyridamole can reduce myocardial injury sustained during elective PCI.

Timeline

Start
2008-10
Primary completion
2010-01
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dipyridamole Other / unclassified 200 mg